Site icon Youth Ki Awaaz

Explained: What We Know About The Nobel-Winning Randomised Controlled Trial

By Kaustav K. Sarkar and Rukmini Thapa

Esther Duflo, Michael Kremer and Abhijit Banerjee received the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel (or the Economic Nobel Prize) in 2019. The mainstream print, broadcast and social media in India (and across the globe) have been full of praise for the Nobel laureates.

As Indians, it is indeed a moment of pride that has been written in the glorious pages of our history. Esther Duflo needs special mention for being the second woman to win a Nobel Prize in Economics. It is also good news that after a long time the Nobel committee has decided to confer the award to economists who have been working very closely to poverty and development issues.

However, a section of development economics, especially experts from the heterodox school of thought (like Naila Kabeer, Ingrid H. Kvangraven, Sanjay Reddy, Jean Dreze, Angus Deaton, to name a few) have been expressing their concerns and reservations about Randomised Controlled Trial (RCT). The jubilation and hullabaloo over the award seem to be overlooking key issues in RCT that must be flagged at this opportune moment. This piece is an effort to highlight some key aspects by drawing from the writings and arguments from the Heterodox School of economics.

RCT borrows the concept from the field of medicine where the effect of a drug needs to be evaluated before it is to be released for the masses. Therefore, in medical research, two identical groups are identified among which only the ‘treatment group’ is given the medicine while the ‘control group’ is not.

Later, researchers find out the impact of the medicine by comparing the treatment and control groups. Esther Duflo and her team implemented this concept in the field of economics, to be very specific in development economics. They have widely used RCTs to measure the impact of various policies in the fields of micro-credit, health, education, nutrition, poverty etc.

Since the announcement of the award, a lot has already been written on RCTs, its methodology and the implications over the past few days. So, to spare the readers from the boredom of repetition, we will skip the theory and only discuss some concerns that make RCTs less appealing to a certain section of academia.

Scholars like Naila Kabeer (who have engaged in field-based research on development economics for quite a long time) expressed that the moment experiments like the RCTs move from a laboratory into a real-world, things perhaps turn upside down. The diverse behaviour of humans, their continuously changing interactions and the evolving culture and society make RCT-like experiments really difficult to carry out in the real world and even replicate it.

To conclude, we hope that the field of development economics welcomes a heterodox academy and remains generously open to a plurality of viewpoints where scholars are encouraged to engage in constructive disagreement. While experiments like RCTs may bring issues like poverty and survey-based research into discourse and limelight again, it also might polarise views and debates. The quest, finally, should be to aim for a sustainable pathway driven by masses themselves as the agents of change.

Note: The authors are a PhD student at the Tata Institute of Social Sciences (Mumbai), and an independent researcher.

Featured Image Credit: Eric Fougere/VIP Images/Corbis/Getty, Jon Chase/Harvard University, Saumya Khandelwal/Hindustan Times/Getty
Exit mobile version